Home / Drug shortages / Podofilox Topical Gel

Podofilox Topical Gel — FDA Drug Shortage

To Be Discontinued — AbbVie Inc.

The FDA lists a drug shortage record for Podofilox Topical Gel (topical gel) from AbbVie Inc. with status To Be Discontinued. The shortage was first posted on 01/28/2026.

Shortage Details

Status
To Be Discontinued
Company
AbbVie Inc.
Package NDC
0023-6118-03
Dosage Form
Topical Gel
Presentation
Condylox , Topical Gel, 0.5% (NDC 0023-6118-03)
Initial Posting
01/28/2026
Revised Date

FDA data resources